Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they
stop growing or die. Monoclonal antibodies such as trastuzumab can locate tumor cells and
kill them without harming normal cells. Combining monoclonal antibody therapy with
chemotherapy may kill more tumor cells. Phase II trial to study the effectiveness of
chemotherapy with or without trastuzumab in treating patients who have metastatic
osteosarcoma